OptimizeRx Corp (OPRX)
12.15
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 16:00
12.13
-0.02
(-0.16%)
After-Hours: 20:00
OptimizeRx Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2019 | 0.8498M |
September 30, 2019 | 1.034M |
June 30, 2019 | 0.2219M |
March 31, 2019 | 0.1762M |
December 31, 2018 | 0.2357M |
September 30, 2018 | 0.1146M |
June 30, 2018 | 0.1194M |
March 31, 2018 | 0.2466M |
December 31, 2017 | 0.3559M |
September 30, 2017 | 0.1032M |
June 30, 2017 | 0.0883M |
March 31, 2017 | 0.1958M |
December 31, 2016 | 0.1538M |
September 30, 2016 | 0.0972M |
June 30, 2016 | 0.0728M |
March 31, 2016 | 0.0746M |
December 31, 2015 | 0.3578M |
September 30, 2015 | 0.0758M |
June 30, 2015 | 0.0564M |
March 31, 2015 | 0.0504M |
December 31, 2014 | 0.0633M |
September 30, 2014 | 0.0581M |
Date | Value |
---|---|
June 30, 2014 | 0.036M |
March 31, 2014 | 0.0321M |
December 31, 2013 | -0.1201M |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 | |
December 31, 2010 | |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 | |
September 30, 2009 | |
June 30, 2009 | 0.042M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.1762M
Minimum
Mar 2019
1.034M
Maximum
Sep 2019
0.5705M
Average
0.5358M
Median